Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination.

Authors :: Bocchino M
Rea G
Buonocore A
Lieto R
Mazzocca A
Di Domenico A
Stanziola AA
Source :: Respiratory medicine case reports [Respir Med Case Rep] 2022 May 24; Vol. 38, pp. 101674. Date of Electronic Publication: 2022 May 24 (Print Publication: 2022).
Publication Year :: 2022
Abstract: Coronavirus disease-2019 (COVID-19) is a systemic disorder with the lung and the vasculature being the preferred targets. Patients with interstitial lung diseases represent a category at high risk of progression in the case of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection, and as such deserve special attention. We first describe the combination of acute exacerbation and pulmonary embolism in an elderly ILD patient after booster anti-COVID-19 mRNA vaccination. Vaccines availability had significantly and safety impacted COVID-19 morbidity and mortality worldwide. Immunization against COVID-19 is indisputable but must not be separated from the awareness of potential adverse effects in fragile patients.<br />Competing Interests: The Authors have no conflict of interest to declare.<br /> (© 2022 Published by Elsevier Ltd.)

Full Text Access

Tools